Total Payments
$4,975
2024 Payments
$1,052
Companies
25
Transactions
244
Medicare Patients
1,002
Medicare Billing
$494,329
Payment Breakdown by Category
Food & Beverage$4,825 (97.0%)
Education$149.99 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,825 | 242 | 97.0% |
| Education | $149.99 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $882.91 | 48 | $0 (2024) |
| Amgen Inc. | $665.85 | 34 | $0 (2024) |
| ABBVIE INC. | $559.47 | 39 | $0 (2024) |
| Lilly USA, LLC | $528.54 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $461.84 | 14 | $0 (2022) |
| UCB, Inc. | $426.36 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $291.89 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $230.00 | 10 | $0 (2024) |
| PFIZER INC. | $164.81 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $143.97 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,052 | 53 | Lilly USA, LLC ($241.14) |
| 2023 | $1,464 | 70 | Janssen Biotech, Inc. ($352.19) |
| 2022 | $1,331 | 64 | UCB, Inc. ($255.73) |
| 2021 | $1,127 | 57 | AstraZeneca Pharmaceuticals LP ($222.86) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $26.89 | General |
| 12/03/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $5.85 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/01/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $121.88 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/10/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $10.50 | General |
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/05/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Immunology | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $27.37 | General |
| Category: Immunology | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 363 | 20,600 | $966,124 | $250,120 |
| 2022 | 8 | 229 | 11,541 | $670,183 | $211,301 |
| 2021 | 9 | 241 | 379 | $67,289 | $19,741 |
| 2020 | 8 | 169 | 263 | $47,354 | $13,168 |
Total Patients
1,002
Total Services
32,783
Medicare Billing
$494,329
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 29 | 18,750 | $750,000 | $191,568 | 25.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 1,140 | $52,440 | $21,075 | 40.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 62 | 282 | $51,551 | $12,856 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 112 | $39,154 | $9,101 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 35 | $16,303 | $3,667 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $16,491 | $3,474 | 21.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 36 | $14,076 | $3,392 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,688 | $1,681 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 21 | $5,775 | $1,064 | 18.4% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 51 | $4,386 | $1,023 | 23.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 59 | $4,425 | $585.28 | 13.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 12 | 37 | $2,035 | $407.00 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 15 | $225.00 | $126.00 | 56.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 11 | 23 | $575.00 | $101.34 | 17.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 23 | 8,700 | $348,000 | $102,347 | 29.4% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 2,500 | $237,500 | $86,210 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 106 | $29,621 | $8,619 | 29.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 42 | 116 | $20,174 | $5,168 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $17,038 | $4,376 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 33 | $12,315 | $3,383 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 19 | $3,596 | $883.12 | 24.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 35 | $1,939 | $313.64 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 86 | $22,016 | $7,048 | 32.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 36 | $12,276 | $4,042 | 32.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $10,500 | $2,854 | 27.2% |
About Caitlyn Erickson, PA
Caitlyn Erickson, PA is a Medical healthcare provider based in Hillsboro, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2018. The National Provider Identifier (NPI) number assigned to this provider is 1043793581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caitlyn Erickson, PA has received a total of $4,975 in payments from pharmaceutical and medical device companies, with $1,052 received in 2024. These payments were reported across 244 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,825).
As a Medicare-enrolled provider, Erickson has provided services to 1,002 Medicare beneficiaries, totaling 32,783 services with total Medicare billing of $494,329. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Hillsboro, OR
- Active Since 09/11/2018
- Last Updated 10/29/2020
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1043793581
Products in Payments
- TALTZ (Drug) $518.04
- RINVOQ (Biological) $492.01
- Cimzia (Drug) $406.36
- SIMPONI ARIA (Biological) $383.84
- SAPHNELO (Biological) $354.66
- TREMFYA (Drug) $324.44
- Enbrel (Biological) $233.87
- BENLYSTA (Biological) $230.00
- KRYSTEXXA (Biological) $206.05
- COSENTYX (Drug) $179.16
- REMICADE (Biological) $174.63
- ORENCIA (Biological) $167.97
- XELJANZ (Drug) $164.81
- COSENTYX (Biological) $94.55
- LUPKYNIS (Drug) $90.27
- STRENSIQ (Biological) $74.10
- PURIFIED CORTROPHIN GEL (Drug) $61.44
- TAVNEOS (Drug) $53.21
- EVENITY (Biological) $49.62
- Tavneos (Drug) $46.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Hillsboro
Mrs. Ashley Scaglione, Pa-C, PA-C
Medical — Payments: $5,244
Medical $5,244
Ms. Jessica Hughbanks, Pa, PA
Medical — Payments: $601.35
Medical $601.35
Ann Owens, Pa-C, PA-C
Medical — Payments: $583.27
Medical $583.27
Emily Boen, Pa-C, PA-C
Medical — Payments: $478.12
Medical $478.12
Justin Rocha, Pa-C, PA-C
Medical — Payments: $465.39
Medical $465.39
Mackenzie Roth, Pa, PA
Medical — Payments: $142.08
Medical $142.08